No UV/IR Mixing in Unitary Space-Time Noncommutative Field Theory

In this article we calculate several divergent amplitudes in phi^4-theory on non-commutative space-time in the framework of Interaction Point Time Ordered Perturbation Theory (IPTOPT), continuing work done in hep-th/0209253. On the ground of these results we find corresponding Feynman rules which allow for a much easier diagrammatic calculation of amplitudes. The most important feature of the present theory is the lack of the UV/IR mixing problem in all amplitudes calculated so far. Although we are not yet able to give a rigorous proof, we provide a strong argument for this result to hold in general. Together with the found Feynman rules this opens promising vistas towards the systematic renormalization of non-commutative field theories.Comment: 23 pages, uses package feynmf, v2: typos, added reference, minor improvement

Space/time noncommutative field theories and causality

As argued previously, amplitudes of quantum field theories on noncommutative space and time cannot be computed using naive path integral Feynman rules. One of the proposals is to use the Gell-Mann--Low formula with time-ordering applied before performing the integrations. We point out that the previously given prescription should rather be regarded as an interaction point time-ordering. Causality is explicitly violated inside the region of interaction. It is nevertheless a consistent procedure, which seems to be related to the interaction picture of quantum mechanics. In this framework we compute the one-loop self-energy for a space/time noncommutative \phi^4 theory. Although in all intermediate steps only three-momenta play a role, the final result is manifestly Lorentz covariant and agrees with the naive calculation. Deriving the Feynman rules for general graphs, we show, however, that such a picture holds for tadpole lines only.Comment: 16 pages, LaTeX, uses feynmf macros, one reference added; ooops, version 2 was an older one

Trace Anomaly in Quantum Spacetime Manifold

In this paper we investigate the trace anomaly in a spacetime where single events are de-localized as a consequence of short distance quantum coordinate fluctuations. We obtain a modified form of heat kernel asymptotic expansion which does not suffer from short distance divergences. Calculation of the trace anomaly is performed using an IR regulator in order to circumvent the absence of UV infinities. The explicit form of the trace anomaly is presented and the corresponding 2D Polyakov effective action and energy momentumtensor are obtained. The vacuum expectation value of the energy momentum tensor in the Boulware, Hartle-Hawking and Unruh vacua is explicitly calculated in a (rt)-section of a recently found, noncommutative geometry inspired, Schwarzschild-like solution of the Einstein equations. The standard short distance divergences in the vacuum expectation values are regularized in agreement with the absence of UV infinities removed by quantum coordinate fluctuations.Comment: 15pages, RevTex, no figures, 1 Tabl

Are there Local Minima in the Magnetic Monopole Potential in Compact QED?

We investigate the influence of the granularity of the lattice on the potential between monopoles. Using the flux definition of monopoles we introduce their centers of mass and are able to realize continuous shifts of the monopole positions. We find periodic deviations from the $1/r$-behavior of the monopole-antimonopole potential leading to local extrema. We suppose that these meta-stabilities may influence the order of the phase transition in compact QED.Comment: 11 pages, 5 figure

On "full" twisted Poincare' symmetry and QFT on Moyal-Weyl spaces

We explore some general consequences of a proper, full enforcement of the "twisted Poincare'" covariance of Chaichian et al. [14], Wess [50], Koch et al. [34], Oeckl [41] upon many-particle quantum mechanics and field quantization on a Moyal-Weyl noncommutative space(time). This entails the associated braided tensor product with an involutive braiding (or $\star$-tensor product in the parlance of Aschieri et al. [3,4]) prescription for any coordinates pair of $x,y$ generating two different copies of the space(time); the associated nontrivial commutation relations between them imply that $x-y$ is central and its Poincar\'e transformation properties remain undeformed. As a consequence, in QFT (even with space-time noncommutativity) one can reproduce notions (like space-like separation, time- and normal-ordering, Wightman or Green's functions, etc), impose constraints (Wightman axioms), and construct free or interacting theories which essentially coincide with the undeformed ones, since the only observable quantities involve coordinate differences. In other words, one may thus well realize QM and QFT's where the effect of space(time) noncommutativity amounts to a practically unobservable common noncommutative translation of all reference frames.Comment: Latex file, 24 pages. Final version to appear in PR

Submucosal diclofenac for acute postoperative pain in third molar surgery: A randomized, controlled clinical trial

Diclofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief of inflammatory pain. A recent formulation combines this drug with hydroxypropyl-β-cyclodextrin (HPβCD) to improve its solubility and to enable subcutaneous administration. Previous studies confirmed the efficacy of this combination. This study’s aim was to evaluate the efficacy, safety, and local tolerability of diclofenac HPβCD administered as a local submucosal injection prior to lower third molar surgery. We conducted a prospective, randomized, double-blind, placebo-controlled, parallel-group phase II single-center study. Seventy-five patients requiring mandibular third molar surgery were randomized into 1 of 5 groups: 5 mg/1 mL diclofenac HPβCD, 12.5 mg/1 mL diclofenac HPβCD, 25 mg/1 mL diclofenac HPβCD, 50 mg/1 mL diclofenac HPβCD, or 1 mL placebo. The respective study drug was injected into the mucosal tissue surrounding the surgical site prior to surgery following achievement of local anesthesia. The primary outcome measure was the area under the curve (AUC) of cumulative pain scores from end of surgery to 6 h postsurgery. This demonstrated a global treatment effect between the active groups and placebo, hence confirming the study drug’s efficacy (P = 0.0126). Secondary outcome measures included the time until onset of pain and the time until patients required rescue medication, both showing statistical significance of the study drug compared to placebo (P < 0.0161 and P < 0.0001, respectively). The time until rescue medication ranged between 7.8 h (for 25 mg/1 mL diclofenac HPβCD) and 16 h (for 50 mg/1 mL diclofenac HPβCD). Interestingly, the 5-mg/1-mL solution appeared superior to the 12.5-mg/1-mL and 25-mg/1-mL solutions (time until rescue medication = 12.44 h). A total of 14% of patients experienced minor adverse drug reactions (ADRs), of which 2 cases demonstrated flap necrosis. These resolved without further intervention. The study results overall indicate efficacy, safety, and relative tolerability of diclofenac HPβCD used locally as a submucosal injection prior to third molar surgery (ClinicalTrials.gov NCT01706588)

The role of mutations in core protein of hepatitis B virus in liver fibrosis

The core protein of hepatitis B virus encompasses B- and T-cell immunodominant epitopes and subdivided into two domains: the N-terminal and the functional C-terminal consisted phosphorylation sites. Mutations of the core gene may change the conformation of the core protein or cause alteration of important epitopes in the host immune response. In this study twenty nine men (mean age 40 ± 9 years old) with chronic hepatitis B were recruited for direct sequencing of the core gene. Serum ALT and HBV DNA level were measured at the time of liver biopsy. The effects of core protein mutations on patients' characteristics and subsequently mutations in B cell, T helper and cytotoxic T lymphocyte (CTL) epitopes and also C-terminal domain of core protein on the activity of liver disease was evaluated. Liver fibrosis was significantly increased in patients with core protein mutation (1.0 ± 0.8 vs 1.9 ± 1.4 for mean stage of fibrosis P = 0.05). Mutations in CTL epitopes and in phosphorylation sites of C-terminal domain of core protein also were associated with higher liver fibrosis (P = 0.003 and P = 0.04; Fisher's exact test for both). Patients with mutation in C-terminal domain had higher serum ALT (62 ± 17 vs 36 ± 12 IU/l, p = 0.02). Patients with mutations in B cell and T helper epitopes did not show significant difference in the clinical features. Our data suggests that core protein mutations in CTL epitopes and C-terminal domain accompanied with higher stage of liver fibrosis may be due to alterations in the function of core protein

Hybrid Meta-heuristics with VNS and Exact Methods: Application to Large Unconditional and Conditional Vertex p-Centre Problems

Large-scale unconditional and conditional vertex p-centre problems are solved using two meta-heuristics. One is based on a three-stage approach whereas the other relies on a guided multi-start principle. Both methods incorporate Variable Neighbourhood Search, exact method, and aggregation techniques. The methods are assessed on the TSP dataset which consist of up to 71,009 demand points with p varying from 5 to 100. To the best of our knowledge, these are the largest instances solved for unconditional and conditional vertex p-centre problems. The two proposed meta-heuristics yield competitive results for both classes of problems

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

PURPOSE: Deficiency of adenosine deaminase 2 (DADA2) is an inherited inborn error of immunity, characterized by autoinflammation (recurrent fever), vasculopathy (livedo racemosa, polyarteritis nodosa, lacunar ischemic strokes, and intracranial hemorrhages), immunodeficiency, lymphoproliferation, immune cytopenias, and bone marrow failure (BMF). Tumor necrosis factor (TNF-α) blockade is the treatment of choice for the vasculopathy, but often fails to reverse refractory cytopenia. We aimed to study the outcome of hematopoietic cell transplantation (HCT) in patients with DADA2. METHODS: We conducted a retrospective study on the outcome of HCT in patients with DADA2. The primary outcome was overall survival (OS). RESULTS: Thirty DADA2 patients from 12 countries received a total of 38 HCTs. The indications for HCT were BMF, immune cytopenia, malignancy, or immunodeficiency. Median age at HCT was 9 years (range: 2-28 years). The conditioning regimens for the final transplants were myeloablative (n = 20), reduced intensity (n = 8), or non-myeloablative (n = 2). Donors were HLA-matched related (n = 4), HLA-matched unrelated (n = 16), HLA-haploidentical (n = 2), or HLA-mismatched unrelated (n = 8). After a median follow-up of 2 years (range: 0.5-16 years), 2-year OS was 97%, and 2-year GvHD-free relapse-free survival was 73%. The hematological and immunological phenotypes resolved, and there were no new vascular events. Plasma ADA2 enzyme activity normalized in 16/17 patients tested. Six patients required more than one HCT. CONCLUSION: HCT was an effective treatment for DADA2, successfully reversing the refractory cytopenia, as well as the vasculopathy and immunodeficiency. CLINICAL IMPLICATIONS: HCT is a definitive cure for DADA2 with > 95% survival